Factors with impact on the success of protein and virus PEGylation

American Chemical Society, Polymer Preprints, Division of Polymer Chemistry

Volumn 41, Issue 1, 2000, Pages 1012-1013

  Fisher, Derek ^a   Buckley, Bob ^a   Delgado, Cristina ^a   Francis, Gillie ^a   Goodwin, Chris ^a   Kippen, Alistair ^a   Malik, Farooq ^a   Marlow, Sue ^a  

^a PolyMASC Pharmaceuticals plc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLOGY; OPTIMIZATION; PROTEINS; TOXICITY; VIRUSES;

ADENOVIRUS; CYTOKINES; PEGYLATION;

POLYETHYLENE GLYCOLS;

EID: 0033733732     PISSN: 00323934     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Article

References (8)

1. Veronese, F M ; Morpurgo, M Farmaco 1999, 54, 497.
2. Francis, G.E.; Delgado, C.; Fisher, D. In: Stability of protein pharmaceuticals: in vivo pathways of degradation and strategies for protein stabilization, Ahern, T.J & Manning, M., eds. Plenum Press, 1992, pp. 235-263.
3. Delgado, C., Francis, G.E.; Fisher, D Crit. Rev Ther Drug Carr. Sys 1992, 9, 189.
4. Monkarsh, S.P ; Ma, Y.; Aglione, A.; et al. Anal Biochem. 1997, 247, 434.
5. Francis G.E ; Fisher, D ; Delgado, C ; et al. Int. J Hematol. 1998, 68, 1.
6. Francis, G E ; Fisher, D , Delgado, C.; Malik, F. PCT/GB94/01844
7. Delgado, C ; Francis, G.E ; Malik, F.; et al. Pharm Sci. 1997, 3, 59
8. Smith A.E.; O'Riordan, C ; Francis, G.E ; et al. PCT/WO 98/44143